Autism spectrum disorder in children: literary reference and own clinical observation

D.S. Khapchenkova, S.A. Dubyna, V.I. Cherkay


Autism spectrum disorder (ASD) is known as a complex developmental disability. Experts believe that autism presents itself during the first three years of a person’s life. There may be many different factors that make a child more likely to have ASD, including environmental, biologic and genetic factors. The condition is the result of a neurological disorder that has an effect on normal brain function, affecting development of the person’s communication and social interaction skills. Children with autism have issues with non-verbal communication, a wide range of social interactions, and activities that include an element of play and/or banter. Children with ASD often have problems with social, emotional, and communication skills. They might repeat certain behaviors and might not want change in their daily activities. Many people with ASD also have different ways of learning, paying attention, or reacting to things. Signs of ASD manifest during early childhood and typically last throughout a person’s life. Children or adults with ASD might: not point at objects to show interest (for example, not point at an airplane flying over); not look at objects when another person points at them; have trouble relating to others or not have an interest in other people at all; avoid eye contact and want to be alone; have trouble understanding other people’s feelings or talking about their own feelings; prefer not to be held or cuddled, or might cuddle only when they want to; appear to be unaware when people talk to them, but respond to other sounds; be very interested in people, but not know how to talk, play, or relate to them; repeat or echo words or phrases said to them, or repeat words or phrases in place of normal language; have trouble expressing their needs using typical words or motions; not play “pretend” games; repeat actions over and over again; have trouble adapting when a routine changes; have unusual reactions to the way things smell, taste, look, feel, or sound; lose skills they once had (for example, stop saying words they were using). Diagnosing ASD can be difficult since there is no medical test, like a blood test, to diagnose the disorders. Doctors look at the child’s behavior and development to make a diagnosis. ASD can sometimes be detected at 18 months or younger. By the age of 2, the diagnosis can be considered very reliable by an experienced professional. The article described own clinical observation of the patient with ASD. The first manifestations of this disease, data of laboratory and instrumental researches of child are described. The course of psychotherapy by the method of Applied Behavior Analysis in conjunction with the method of sensorimotor correction is described. The positive effect of ongoing psychotherapy in the patient is marked.


children; autism; social maladjustment


Pakulova-Trockaja JuV, Njan'kovskij SL. Problems of somatic pathology in children with autism spectrum disorders. Health of the child. 2016; 1(69):63-67. (In Russian).

Romanchuk OІ. Rozladi spektra autizmu v zapitannjah ta vіdpovіdjah [Autism spectrum disorders in questions and answers]. Lviv: Koleso. 2009. 163 p. (In Ukrainian).

Bobylova MJu, Vinjarskaja IV, Bystrova KJu, Narovatkina JuK. Atypical autism in children: features of somato-neurological status and outpatient monitoring of general pediatric profile. Russian Journal of Pediatric Neurology. 2014; VIII-IX(1):42-51. (In Russian).

Isaksen J, Bryn V, Diseth TH. Children with autism spectrum disorders: The importance of medical investigations. European Journal of Paediatric Neurology. 2012; 17(1):68-76.

The survey "Autism in Ukraine Today": three problems – specialists, diagnostics, officials. Available from: Accessed: 2015.

Simashkova NV. Rasstrojstva autisticheskogo spektra u detej: nauchno-prakticheskoe rukovodstvo [Autistic Spectrum Disorders in Children: A Scientific and Practical Guide]. Moscow: Avtorskaja akademija. 2013. 264 p. (In Russian).

Belousova MV, Prusakova VF, Utkuzova MA. Disorders of the autism spectrum in the practice of a pediatrician. Psychology. Medicine. 2009;6(38):36-40. (In Russian).

Grigor'eva NK. The problem of autism in childhood. Psychotherapy and clinical psychology: scientific-practical peer-reviewed journal. 2010;1:5-12. (In Russian).

Golimbet VE, Koren' EV. Variations in the number of copies in the genome – a new page in genetic research in the psychiatry: the international project PsychCNVs. Journal of Neurology and Psychiatry named by S.S. Korsakov. 2010;1:107-109. (In Russian).

Brooks-Kayal A. Molecular mechanisms of cognitive and behavioral comorbidities of epilepsy in children. Epilepsia. 2011;52 (1):13-20.

Grechanina EJa. Autism. Genetic and epigenetic problems. Scientific Journal of the Ministry of Health of Ukraine. 2013; 2:29-48. Access mode: (In Russian).

King BH. Promising forecast for autism spectrum disorders. Journal of the American Medical Association. 2015;313(15):1518-1519. – doi:10.1001/jama.2015.2628.

Aldred S, Moore KM, Fitzgerald M, Waring RH. Plasma amino acid levels in children with autism and their families. J. Autism Dev. 2003;33(1):83-97.

Muchle R. et al. The Genetics of Autism. Pediatrics. 2004;133: 472-486.

Carlsson M. Hypothesis: is infantile autism a hypoglutamatergic disorder? Relevance of glutamate serotonin interactions for pharmacotherapy. J. Neural. Transm. 1998;105:525-535.

Puangpetch A, Suwannarat P, Chamnanphol M Significant Association of HLA-B Alleles and Genotypes in Thai Children with Autism Spectrum Disorders: A Case-Control Study . Dis. Markers. 2015;2015:724-935.

Wasilewska J, Kaczmarski M, Stasiak-Barmuta A. Low serum IgA and increased expression of CD23 on B lymphocytes in peripheral blood in children with regressive autism aged 3–6 years old. Arch. Med. Sci. 2012; 8 (2):324-331.

Cabanlit M, Wills S, Goines P. Brain-specific autoantibodies in the plasma of subjects with autistic spectrum disorder. Ann. N.Y. Acad. Sci. 2007;107:92-103.

Mostafa GA, Al-Ayadhi LY. Increased serum levels of anti-ganglioside M1 auto-antibodies in autistic children: relation to the disease severity. J.Neuroinflammation. 2011;25:8-39.

Niederhofer H, Staffen W, Mair A. Immunoglobulins as an alternative strategy of psychopharmacological treatment of children with autistic disorder. Neuropsychopharmacology. 2003;28 (5):1014-1015.

Medical comorbidities in autism spectrum disorders. Available from: Medical-Comorbidities-in-Autism-Spectrum-Disorders-2013.pdf. Accessed: March, 2013. (In Russian).

Chen B, Girgis S, El-Matary W. Childhood autism and eosinophilic colitis .J. Digestion. 2010;81(2): 127-129. Dоі: 10.1159/000252765.

Jyonouchi H. Autism spectrum disorders and allergy: observation from a pediatric allergy/immunology clinic. Expert Review of Clinical Immunology. 2010; 6(3): 397-411. PMID: 15870662.

Manzi B. Autism and metabolic diseases. J. Child Neurol. 2008;23(3):307-314.

Frye RE. Metabolic and mitochondrial disorders associated with epilepsy in children with autism spectrum disorder. Epilepsy Behav. 2015;47:147-57. – doi: 10.1016/j.yebeh.2014.08.134.

Marcenkovs'kij ІA. General principles of therapy for children with autism spectrum disorders Arch. Psychiatry. 2011;17(4):67-70. (In Ukrainian).

Gorjacheva TG., Sultanova AS. Sensomotor correction for various deviations of the mental development. Neurological bulletin named by V. M. Bekhterew. 2008;XL(3):56-60.

Bondy A, Frost L. A picture′s worth: PECS and other visual communication strategies in autism. 2nd ed. Bethesda, MD: Woodbine House; 2011. 143p.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.


© Publishing House Zaslavsky, 1997-2020


   Seo анализ сайта